Kaseta Michael — SEC Form 4 filings

SEC reporting owner CIK 1724346. 31 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2024-01-16 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Liquidia Corp (LQDA)CFO and COO2630 legs · 527,536 sh · $18,328,99659
HERON THERAPEUTICS, INC. /DE/ (HRTX)Director47
ALIMERA SCIENCES INC (ALIM)Director12

Form 4 filings — Kaseta Michael

FiledFormIssuerReported transactionsSource
2026-07-144Liquidia Corp (LQDA)Option exercise (M): 5,829 · Option exercise (M): 7,050 · Sale (S): 1,453 @ $71.39 · Sale (S): 18,977 @ $71.52 · Option exercise (M): 5,829 (derivative) @ $0 · Option exercise (M): 7,050 (derivative) @ $0EDGAR
2026-04-164Liquidia Corp (LQDA)Option exercise (M): 3,000 @ $2.79 · Sale (S): 3,000 @ $40 · Sale (S): 9,044 @ $40.14 · Option exercise (M): 86,971 @ $2.79 · Sale (S): 86,971 @ $40.14 · Sale (S): 43,375 @ $40.14 · +2 moreEDGAR
2026-04-144Liquidia Corp (LQDA)Option exercise (M): 23,821 @ $2.79 · Sale (S): 23,821 @ $40.14 · Option exercise (M): 5,828 · Option exercise (M): 7,050 · Sale (S): 18,958 @ $38.37 · Option exercise (M): 23,821 (derivative) @ $0 · +2 moreEDGAR
2026-04-134Liquidia Corp (LQDA)Option exercise (M): 19,042 @ $2.79 · Option exercise (M): 86,632 @ $2.79 · Option exercise (M): 18,115 @ $2.97 · Option exercise (M): 728 @ $2.54 · Option exercise (M): 9,272 @ $2.54 · Sale (S): 133,789 @ $40.24 · +5 moreEDGAR
2026-03-034Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,165 @ $30.58 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2026-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 53,960 @ $0EDGAR
2026-01-214Liquidia Corp (LQDA)Grant/award (A): 59,320 @ $0 · Grant/award (A): 88,980 (derivative) @ $0EDGAR
2026-01-134Liquidia Corp (LQDA)Option exercise (M): 5,828 · Option exercise (M): 28,200 · Sale (S): 36,932 @ $37.43 · Option exercise (M): 5,828 (derivative) @ $0 · Option exercise (M): 28,200 (derivative) @ $0EDGAR
2025-12-024Liquidia Corp (LQDA)Option exercise (M): 2,343 · Sale (S): 1,166 @ $32.19 · Option exercise (M): 2,343 (derivative) @ $0EDGAR
2025-10-154Liquidia Corp (LQDA)Option exercise (M): 5,828 · Sale (S): 11,630 @ $23.41 · Option exercise (M): 5,828 (derivative) @ $0EDGAR
2025-09-034Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,148 @ $29.05 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2025-08-194Liquidia Corp (LQDA)Sale (S): 20,000 @ $26.18EDGAR
2025-08-074Liquidia Corp (LQDA)Sale (S): 30,000 @ $20.00EDGAR
2025-07-154Liquidia Corp (LQDA)Option exercise (M): 5,828 · Sale (S): 11,580 @ $14.28 · Option exercise (M): 5,828 (derivative) @ $0EDGAR
2025-06-054Liquidia Corp (LQDA)Option exercise (M): 29,141 · Sale (S): 14,777 @ $16.97 · Option exercise (M): 29,141 (derivative) @ $0EDGAR
2025-06-034Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 859 @ $16.74 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2025-04-164Liquidia Corp (LQDA)Sale (S): 8,283 @ $13.57EDGAR
2025-03-044Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 874 @ $15.45 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2025-02-044/AHERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0EDGAR
2025-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73EDGAR
2025-01-144Liquidia Corp (LQDA)Grant/award (A): 112,797 @ $0 · Sale (S): 23,370 @ $11.78 · Grant/award (A): 112,797 (derivative) @ $0EDGAR
2024-12-034Liquidia Corp (LQDA)Option exercise (M): 2,343 · Sale (S): 1,091 @ $11.51 · Option exercise (M): 2,343 (derivative) @ $0EDGAR
2024-11-064HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 37,879 · Grant/award (A): 227,272 (derivative) @ $1.78EDGAR
2024-10-154Liquidia Corp (LQDA)Sale (S): 3,892 @ $11.11EDGAR
2024-09-184ALIMERA SCIENCES INC (ALIM)Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 1,825 (derivative)EDGAR
2024-09-044Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,079 @ $9.50 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2024-07-154Liquidia Corp (LQDA)Sale (S): 3,906 @ $12.53EDGAR
2024-06-044Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,094 @ $14.55 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2024-04-164Liquidia Corp (LQDA)Sale (S): 3,136 @ $14.58EDGAR
2024-03-194Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 851 @ $15.82 · Sale (S): 11,315 @ $15.82 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2024-01-164Liquidia Corp (LQDA)Grant/award (A): 93,250 @ $0 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 93,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724346 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →